Study of Oral PG-116800 Following a Heart Attack

Summary

The main purpose of the study is to test whether a possible new drug (called PG-116800) can prevent some of the damage to heart muscle in patients who have had a heart attack. The study will also supply information regarding possible uses of this compound in cardiovascular disease.

Timeline

Start

2003-09

Primary completion

2004-12

Completion

2004-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Placebo vs PG-116800 Tablet; p = 0.4239; Mean Difference (Net) 4; ANOVA NCT00067236 ↗

Drugs

Indications